{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:04:17Z","timestamp":1793977457695,"version":"4.8.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Up-regulation of utrophin in muscles represents a promising therapeutic strategy for the treatment of Duchenne Muscular Dystrophy. We previously demonstrated that eEF1A2 associates with the 5\u2019UTR of utrophin A to promote IRES-dependent translation. Here, we examine whether eEF1A2 directly regulates utrophin A expression and identify via an ELISA-based high-throughput screen, FDA-approved drugs that upregulate both eEF1A2 and utrophin A. Our results show that transient overexpression of eEF1A2 in mouse muscles causes an increase in IRES-mediated translation of utrophin A. Through the assessment of our screen, we reveal 7 classes of FDA-approved drugs that increase eEF1A2 and utrophin A protein levels. Treatment of mdx mice with the 2 top leads results in multiple improvements of the dystrophic phenotype. Here, we report that IRES-mediated translation of utrophin A via eEF1A2 is a critical mechanism of regulating utrophin A expression and reveal the potential of repurposed drugs for treating DMD via this pathway.<\/jats:p>","DOI":"10.1038\/s41467-020-15971-w","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T10:27:15Z","timestamp":1587724035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Identification of therapeutics that target eEF1A2 and upregulate utrophin A translation in dystrophic muscles"],"prefix":"10.1038","volume":"11","author":[{"given":"Christine","family":"P\u00e9ladeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas M.","family":"Bronicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e8le","family":"Coriati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Thabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasanen","family":"Al-Rewashdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8411-2664","authenticated-orcid":false,"given":"Jason","family":"Vanstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Mears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Holcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Jasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"15971_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1152\/physrev.00028.2001","volume":"82","author":"DJ Blake","year":"2002","unstructured":"Blake, D. J., Weir, A., Newey, S. E. & Davies, K. E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiological Rev. 82, 291\u2013329 (2002).","journal-title":"Physiological Rev."},{"key":"15971_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/345315a0","volume":"345","author":"JM Ervasti","year":"1990","unstructured":"Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G. & Campbell, K. P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315\u2013319 (1990).","journal-title":"Nature"},{"key":"15971_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman, E. P., Brown, R. H. & Kunkel, L. M. Dystrophin: The protein product of the duchenne muscular dystrophy locus. Cell 51, 919\u2013928 (1987).","journal-title":"Cell"},{"key":"15971_CR4","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.2147\/DDDT.S110163","volume":"10","author":"S Miyatake","year":"2016","unstructured":"Miyatake, S., Shimizu-Motohashi, Y., Takeda, S. & Aoki, Y. Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors. Drug Des. Devel Ther. 10, 2745\u20132758 (2016).","journal-title":"Drug Des. Devel Ther."},{"key":"15971_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant, D. J. et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 17, 347\u2013361 (2018).","journal-title":"Lancet Neurol."},{"key":"15971_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/mus.880100212","volume":"10","author":"JR Bach","year":"1987","unstructured":"Bach, J. R., O\u2019Brien, J., Krotenberg, R. & Alba, A. S. Management of end stage respiratory failure in Duchenne muscular dystrophy. Muscle Nerve 10, 177\u2013182 (1987).","journal-title":"Muscle Nerve"},{"key":"15971_CR7","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/4033","volume":"4","author":"J Tinsley","year":"1998","unstructured":"Tinsley, J. et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat. Med. 4, 1441\u20131444 (1998).","journal-title":"Nat. Med."},{"key":"15971_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/384349a0","volume":"384","author":"JM Tinsley","year":"1996","unstructured":"Tinsley, J. M. et al. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384, 349\u2013353 (1996).","journal-title":"Nature"},{"key":"15971_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coph.2017.04.002","volume":"34","author":"S Guiraud","year":"2017","unstructured":"Guiraud, S. & Davies, K. E. Pharmacological advances for treatment in Duchenne muscular dystrophy. Curr. Opin. Pharm. 34, 36\u201348 (2017).","journal-title":"Curr. Opin. Pharm."},{"key":"15971_CR10","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/hmg\/ddr265","volume":"20","author":"V Ljubicic","year":"2011","unstructured":"Ljubicic, V. et al. Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle. Hum. Mol. Genet. 20, 3478\u20133493 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"15971_CR11","doi-asserted-by":"publisher","first-page":"C66","DOI":"10.1152\/ajpcell.00357.2013","volume":"307","author":"V Ljubicic","year":"2014","unstructured":"Ljubicic, V., Burt, M., Lunde, J. A. & Jasmin, B. J. Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1\u03b1 axis. Am. J. Physiol., Cell Physiol. 307, C66\u201382 (2014).","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"15971_CR12","doi-asserted-by":"publisher","first-page":"e2309","DOI":"10.1371\/journal.pone.0002309","volume":"3","author":"P Miura","year":"2008","unstructured":"Miura, P., Andrews, M., Holcik, M. & Jasmin, B. J. IRES-Mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells. PLoS ONE 3, e2309 (2008).","journal-title":"PLoS ONE"},{"key":"15971_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/hmg\/ddv444","volume":"25","author":"C P\u00e9ladeau","year":"2016","unstructured":"P\u00e9ladeau, C. et al. Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles. Hum. Mol. Genet. 25, 24\u201343 (2016).","journal-title":"Hum. Mol. Genet"},{"key":"15971_CR14","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1096\/fj.201800081R","volume":"32","author":"C P\u00e9ladeau","year":"2018","unstructured":"P\u00e9ladeau, C., Adam, N. J. & Jasmin, B. J. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression. FASEB J. 32, 5090\u20135103 (2018).","journal-title":"FASEB J."},{"key":"15971_CR15","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1073\/pnas.0932671100","volume":"100","author":"JV Chakkalakal","year":"2003","unstructured":"Chakkalakal, J. V. et al. Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin\/NFAT signaling. Proc. Natl Acad. Sci. USA 100, 7791\u20137796 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15971_CR16","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/nar\/24.9.1646","volume":"24","author":"CL Dennis","year":"1996","unstructured":"Dennis, C. L., Tinsley, J. M., Deconinck, A. E. & Davies, K. E. Molecular and functional analysis of the utrophin promoter. Nucleic Acids Res. 24, 1646\u20131652 (1996).","journal-title":"Nucleic Acids Res."},{"key":"15971_CR17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1006\/jmbi.2000.4335","volume":"306","author":"F Galvagni","year":"2001","unstructured":"Galvagni, F., Capo, S. & Oliviero, S. Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter. J. Mol. Biol. 306, 985\u2013996 (2001).","journal-title":"J. Mol. Biol."},{"key":"15971_CR18","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1093\/nar\/27.17.3603","volume":"27","author":"AO Gramolini","year":"1999","unstructured":"Gramolini, A. O. & Jasmin, B. J. Expression of the utrophin gene during myogenic differentiation. Nucleic Acids Res. 27, 3603\u20133609 (1999).","journal-title":"Nucleic Acids Res."},{"key":"15971_CR19","doi-asserted-by":"publisher","first-page":"8117","DOI":"10.1074\/jbc.272.13.8117","volume":"272","author":"AO Gramolini","year":"1997","unstructured":"Gramolini, A. O. et al. Local transcriptional control of utrophin expression at the neuromuscular synapse. J. Biol. Chem. 272, 8117\u20138120 (1997).","journal-title":"J. Biol. Chem."},{"key":"15971_CR20","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1073\/pnas.96.6.3223","volume":"96","author":"AO Gramolini","year":"1999","unstructured":"Gramolini, A. O. et al. Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. Proc. Natl Acad. Sci. USA 96, 3223\u20133227 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15971_CR21","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1091\/mbc.10.6.2075","volume":"10","author":"TS Khurana","year":"1999","unstructured":"Khurana, T. S. et al. Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha\/beta. Mol. Biol. Cell 10, 2075\u20132086 (1999).","journal-title":"Mol. Biol. Cell"},{"key":"15971_CR22","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1093\/nar\/29.23.4843","volume":"29","author":"KJ Perkins","year":"2001","unstructured":"Perkins, K. J., Burton, E. A. & Davies, K. E. The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy. Nucleic Acids Res. 29, 4843\u20134850 (2001).","journal-title":"Nucleic Acids Res."},{"key":"15971_CR23","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1093\/hmg\/ddt165","volume":"22","author":"A Amirouche","year":"2013","unstructured":"Amirouche, A. et al. Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: Implications for novel DMD therapeutics. Hum. Mol. Genet. 22, 3093\u20133111 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"15971_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1042\/BJ20050024","volume":"391","author":"A Bonet-Kerrache","year":"2005","unstructured":"Bonet-Kerrache, A., Fortier, M., Comunale, F. & Gauthier-Rouvi\u00e8re, C. The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane. Biochem J. 391, 261\u2013268 (2005).","journal-title":"Biochem J."},{"key":"15971_CR25","doi-asserted-by":"crossref","unstructured":"Mishra, M. K., Loro, E., Sengupta, K., Wilton, S. D. & Khurana, T. S. Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction. PLoS One 12, e0182676 (2017).","DOI":"10.1371\/journal.pone.0182676"},{"key":"15971_CR26","doi-asserted-by":"publisher","first-page":"e29376","DOI":"10.1371\/journal.pone.0029376","volume":"6","author":"U Basu","year":"2011","unstructured":"Basu, U. et al. Translational Regulation of Utrophin by miRNAs. PLoS ONE 6, e29376 (2011).","journal-title":"PLoS ONE"},{"key":"15971_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00005072-199903000-00003","volume":"58","author":"AO Gramolini","year":"1999","unstructured":"Gramolini, A. O., Karpati, G. & Jasmin, B. J. Discordant expression of utrophin and its transcript in human and mouse skeletal muscles. J. Neuropathol. Exp. Neurol. 58, 235\u2013244 (1999).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"15971_CR28","doi-asserted-by":"publisher","first-page":"14025","DOI":"10.1073\/pnas.96.24.14025","volume":"96","author":"EA Burton","year":"1999","unstructured":"Burton, E. A., Tinsley, J. M., Holzfeind, P. J., Rodrigues, N. R. & Davies, K. E. A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Proc. Natl Acad. Sci. USA 96, 14025\u201314030 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15971_CR29","doi-asserted-by":"publisher","first-page":"e0134809","DOI":"10.1371\/journal.pone.0134809","volume":"10","author":"T Ghosh","year":"2015","unstructured":"Ghosh, T. & Basu, U. Cis-acting sequence elements and upstream open reading frame in mouse utrophin-A 5\u2019-UTR repress cap-dependent translation. PLoS ONE 10, e0134809 (2015).","journal-title":"PLoS ONE"},{"key":"15971_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4161\/cc.10.2.14472","volume":"10","author":"AA Komar","year":"2011","unstructured":"Komar, A. A. & Hatzoglou, M. Cellular IRES-mediated translation. Cell Cycle 10, 229\u2013240 (2011).","journal-title":"Cell Cycle"},{"key":"15971_CR31","doi-asserted-by":"publisher","first-page":"32997","DOI":"10.1074\/jbc.M503994200","volume":"280","author":"P Miura","year":"2005","unstructured":"Miura, P., Thompson, J., Chakkalakal, J. V., Holcik, M. & Jasmin, B. J. The utrophin A 5\u2032-untranslated region confers internal ribosome entry site-mediated translational control during regeneration of skeletal muscle fibers. J. Biol. Chem. 280, 32997\u201333005 (2005).","journal-title":"J. Biol. Chem."},{"key":"15971_CR32","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/hmg\/ddp591","volume":"19","author":"P Miura","year":"2010","unstructured":"Miura, P. et al. The utrophin A 5\u2032-UTR drives cap-independent translation exclusively in skeletal muscles of transgenic mice and interacts with eEF1A2. Hum. Mol. Genet 19, 1211\u20131220 (2010).","journal-title":"Hum. Mol. Genet"},{"key":"15971_CR33","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/nm.3628","volume":"20","author":"N Wein","year":"2014","unstructured":"Wein, N. et al. Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice. Nat. Med 20, 992\u20131000 (2014).","journal-title":"Nat. Med"},{"key":"15971_CR34","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1042\/BST0381581","volume":"38","author":"HA King","year":"2010","unstructured":"King, H. A., Cobbold, L. C. & Willis, A. E. The role of IRES trans-acting factors in regulating translation initiation. Biochemical Soc. Trans. 38, 1581\u20131586 (2010).","journal-title":"Biochemical Soc. Trans."},{"key":"15971_CR35","first-page":"218","volume":"34","author":"U Liwak","year":"2012","unstructured":"Liwak, U., Faye, M. D. & Holcik, M. Translation control in apoptosis. Exp. Oncol. 34, 218\u2013230 (2012).","journal-title":"Exp. Oncol."},{"key":"15971_CR36","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.cdd.4401642","volume":"12","author":"KA Spriggs","year":"2005","unstructured":"Spriggs, K. A., Bushell, M., Mitchell, S. A. & Willis, A. E. Internal ribosome entry segment-mediated translation during apoptosis: the role of IRES-trans-acting factors. Cell Death Differ. 12, 585\u2013591 (2005).","journal-title":"Cell Death Differ."},{"key":"15971_CR37","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1128\/MCB.24.12.5595-5605.2004","volume":"24","author":"BM Pickering","year":"2004","unstructured":"Pickering, B. M., Mitchell, S. A., Spriggs, K. A., Stoneley, M. & Willis, A. E. Bag-1 internal ribosome entry segment activity is promoted by structural changes mediated by poly(rC) binding protein 1 and recruitment of polypyrimidine tract binding protein 1. Mol. Cell. Biol. 24, 5595\u20135605 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"15971_CR38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4306\/pi.2016.13.3.316","volume":"13","author":"B-J Kim","year":"2016","unstructured":"Kim, B.-J., Park, J.-I., Eun, H.-J. & Yang, J.-C. Influence of Betaxolol on the Methamphetamine dependence in mice. Psychiatry Investig. 13, 316\u2013320 (2016).","journal-title":"Psychiatry Investig."},{"key":"15971_CR39","first-page":"54","volume":"6","author":"H Orbay","year":"2013","unstructured":"Orbay, H. et al. Pravastatin stimulates angiogenesis in a murine hindlimb ischemia model: a positron emission tomography imaging study with 64Cu-NOTA-TRC105. Am. J. Transl. Res. 6, 54\u201363 (2013).","journal-title":"Am. J. Transl. Res."},{"key":"15971_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.molmed.2006.01.002","volume":"12","author":"P Miura","year":"2006","unstructured":"Miura, P. & Jasmin, B. J. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? Trends Mol. Med. 12, 122\u2013129 (2006).","journal-title":"Trends Mol. Med."},{"key":"15971_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0960-8966(91)90023-L","volume":"1","author":"TS Khurana","year":"1991","unstructured":"Khurana, T. S. et al. Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul. Disord. 1, 185\u2013194 (1991).","journal-title":"Neuromuscul. Disord."},{"key":"15971_CR42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0896-6273(91)90301-F","volume":"7","author":"K Ohlendieck","year":"1991","unstructured":"Ohlendieck, K. et al. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 7, 499\u2013508 (1991).","journal-title":"Neuron"},{"key":"15971_CR43","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.nmd.2004.06.008","volume":"14","author":"A Briguet","year":"2004","unstructured":"Briguet, A., Courdier-Fruh, I., Foster, M., Meier, T. & Magyar, J. P. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul. Disord. 14, 675\u2013682 (2004).","journal-title":"Neuromuscul. Disord."},{"key":"15971_CR44","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1073\/pnas.95.8.4463","volume":"95","author":"DM Chambers","year":"1998","unstructured":"Chambers, D. M., Peters, J. & Abbott, C. M. The lethal mutation of the mouse wasted (wst) is a deletion that abolishes expression of a tissue-specific isoform of translation elongation factor 1\u03b1, encoded by the Eef1a2 gene. Proc. Natl Acad. Sci. USA 95, 4463\u20134468 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15971_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/297402a0","volume":"297","author":"LD Shultz","year":"1982","unstructured":"Shultz, L. D., Sweet, H. O., Davisson, M. T. & Coman, D. R. \u2018Wasted\u2019, a new mutant of the mouse with abnormalities characteristic to ataxia telangiectasia. Nature 297, 402\u2013404 (1982).","journal-title":"Nature"},{"key":"15971_CR46","doi-asserted-by":"publisher","first-page":"22915","DOI":"10.1074\/jbc.M101011200","volume":"276","author":"A Khalyfa","year":"2001","unstructured":"Khalyfa, A. et al. Characterization of elongation factor-1A (eEF1A-1) and eEF1A-2\/S1 protein expression in normal and wasted mice. J. Biol. Chem. 276, 22915\u201322922 (2001).","journal-title":"J. Biol. Chem."},{"key":"15971_CR47","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1042\/BST0371293","volume":"37","author":"CM Abbott","year":"2009","unstructured":"Abbott, C. M. et al. eEF1A2 and neuronal degeneration. Biochem. Soc. Trans. 37, 1293\u20131297 (2009).","journal-title":"Biochem. Soc. Trans."},{"key":"15971_CR48","doi-asserted-by":"publisher","first-page":"C1300","DOI":"10.1152\/ajpcell.2001.281.4.C1300","volume":"281","author":"AO Gramolini","year":"2001","unstructured":"Gramolini, A. O., B\u00e9langer, G., Thompson, J. M., Chakkalakal, J. V. & Jasmin, B. J. Increased expression of utrophin in a slow vs. a fast muscle involves posttranscriptional events. Am. J. Physiol. - Cell Physiol. 281, C1300\u2013C1309 (2001).","journal-title":"Am. J. Physiol. - Cell Physiol."},{"key":"15971_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-2-16","volume":"2","author":"VE Jahnke","year":"2012","unstructured":"Jahnke, V. E. et al. Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model. Skelet. Muscle 2, 16 (2012).","journal-title":"Skelet. Muscle"},{"key":"15971_CR50","doi-asserted-by":"crossref","unstructured":"Whitehead, N. P., Kim, M. J., Bible, K. L., Adams, M. E. & Froehner, S. C. Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy. Rare Dis 4, e1156286 (2016).","DOI":"10.1080\/21675511.2016.1156286"},{"key":"15971_CR51","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00246-007-9113-z","volume":"29","author":"J Rhodes","year":"2008","unstructured":"Rhodes, J. et al. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr. Cardiol. 29, 343\u2013351 (2008).","journal-title":"Pediatr. Cardiol."},{"key":"15971_CR52","doi-asserted-by":"publisher","first-page":"12864","DOI":"10.1073\/pnas.1509536112","volume":"112","author":"NP Whitehead","year":"2015","unstructured":"Whitehead, N. P., Kim, M. J., Bible, K. L., Adams, M. E. & Froehner, S. C. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Proc. Natl Acad. Sci. USA 112, 12864\u201312869 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15971_CR53","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/15548627.2016.1144005","volume":"12","author":"NP Whitehead","year":"2016","unstructured":"Whitehead, N. P. Enhanced autophagy as a potential mechanism for the improved physiological function by simvastatin in muscular dystrophy. Autophagy 12, 705\u2013706 (2016).","journal-title":"Autophagy"},{"key":"15971_CR54","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1432-1033.1993.tb18064.x","volume":"215","author":"SM Knudsen","year":"1993","unstructured":"Knudsen, S. M., Frydenberg, J., Clark, B. F. & Leffers, H. Tissue-dependent variation in the expression of elongation factor-1 alpha isoforms: isolation and characterisation of a cDNA encoding a novel variant of human elongation-factor 1 alpha. Eur. J. Biochem. 215, 549\u2013554 (1993).","journal-title":"Eur. J. Biochem."},{"key":"15971_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1006\/geno.1996.0475","volume":"36","author":"A Lund","year":"1996","unstructured":"Lund, A., Knudsen, S. M., Vissing, H., Clark, B. & Tommerup, N. Assignment of human elongation factor 1alpha genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13.3. Genomics 36, 359\u2013361 (1996).","journal-title":"Genomics"},{"key":"15971_CR56","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1074\/jbc.M110685200","volume":"277","author":"L-B Ruest","year":"2002","unstructured":"Ruest, L.-B., Marcotte, R. & Wang, E. Peptide elongation factor eEF1A-2\/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis. J. Biol. Chem. 277, 5418\u20135425 (2002).","journal-title":"J. Biol. Chem."},{"key":"15971_CR57","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1432-1033.1993.tb18064.x","volume":"215","author":"SM Knudsen","year":"1993","unstructured":"Knudsen, S. M., Frydenberg, J., Clark, B. F. & Leffers, H. Tissue-dependent variation in the expression of elongation factor-1 alpha isoforms: isolation and characterisation of a cDNA encoding a novel variant of human elongation-factor 1 alpha. Eur. J. Biochem. \/ FEBS 215, 549\u2013554 (1993).","journal-title":"Eur. J. Biochem. \/ FEBS"},{"key":"15971_CR58","doi-asserted-by":"crossref","first-page":"24064","DOI":"10.1016\/S0021-9258(18)35946-5","volume":"267","author":"S Lee","year":"1992","unstructured":"Lee, S., Francoeur, A. M., Liu, S. & Wang, E. Tissue-specific expression in mammalian brain, heart, and muscle of S1, a member of the elongation factor-1 alpha gene family. J. Biol. Chem. 267, 24064\u201324068 (1992).","journal-title":"J. Biol. Chem."},{"key":"15971_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.freeradbiomed.2013.10.015","volume":"67","author":"S Arg\u00fcelles","year":"2014","unstructured":"Arg\u00fcelles, S., Camandola, S., Cutler, R. G., Ayala, A. & Mattson, M. P. Elongation factor 2 diphthamide is critical for translation of two IRES-dependent protein targets, XIAP and FGF2, under oxidative stress conditions. Free Radic. Biol. Med. 67, 131\u2013138 (2014).","journal-title":"Free Radic. Biol. Med."},{"key":"15971_CR60","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1146\/annurev.bi.54.070185.005333","volume":"54","author":"K Moldave","year":"1985","unstructured":"Moldave, K. Eukaryotic protein synthesis. Annu. Rev. Biochem. 54, 1109\u20131149 (1985).","journal-title":"Annu. Rev. Biochem."},{"key":"15971_CR61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.virol.2003.10.028","volume":"321","author":"D Matsuda","year":"2004","unstructured":"Matsuda, D., Yoshinari, S. & Dreher, T. W. eEF1A binding to aminoacylated viral RNA represses minus strand synthesis by TYMV RNA-dependent RNA polymerase. Virology 321, 47\u201356 (2004).","journal-title":"Virology"},{"key":"15971_CR62","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1093\/emboj\/cdg523","volume":"22","author":"J Pogany","year":"2003","unstructured":"Pogany, J., Fabian, M. R., White, K. A. & Nagy, P. D. A replication silencer element in a plus-strand RNA virus. EMBO J. 22, 5602\u20135611 (2003).","journal-title":"EMBO J."},{"key":"15971_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1128\/JVI.71.9.6433-6444.1997","volume":"71","author":"JL Blackwell","year":"1997","unstructured":"Blackwell, J. L. & Brinton, M. A. Translation elongation factor-1 Alpha interacts with the 3\u0408 stem-loop region of West Nile virus genomic RNA. J. VIROL 71, 12 (1997).","journal-title":"J. VIROL"},{"key":"15971_CR64","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1261\/rna.157806","volume":"12","author":"SD Baird","year":"2006","unstructured":"Baird, S. D., Turcotte, M., Korneluk, R. G. & Holcik, M. Searching for IRES. RNA 12, 1755 (2006).","journal-title":"RNA"},{"key":"15971_CR65","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/sj.onc.1210777","volume":"27","author":"SM Lewis","year":"2008","unstructured":"Lewis, S. M. & Holcik, M. For IRES trans-acting factors, it is all about location. Oncogene 27, 1033\u20131035 (2008).","journal-title":"Oncogene"},{"key":"15971_CR66","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"15971_CR67","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan, J. & Kantharia, N. D. How to calculate sample size in animal studies? J. Pharm. Pharmacother. 4, 303\u2013306 (2013).","journal-title":"J. Pharm. Pharmacother."},{"key":"15971_CR68","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1073\/pnas.95.8.4463","volume":"95","author":"DM Chambers","year":"1998","unstructured":"Chambers, D. M., Peters, J. & Abbott, C. M. The lethal mutation of the mouse wasted (wst) is a deletion that abolishes expression of a tissue-specific isoform of translation elongation factor 1\u03b1, encoded by the Eef1a2 gene. Proc. Natl Acad. Sci. USA 95, 4463\u20134468 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15971_CR69","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/hmg\/ddu535","volume":"24","author":"H Al-Rewashdy","year":"2015","unstructured":"Al-Rewashdy, H., Ljubicic, V., Lin, W., Renaud, J.-M. & Jasmin, B. J. Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation. Hum. Mol. Genet. 24, 1243\u20131255 (2015).","journal-title":"Hum. Mol. Genet"},{"key":"15971_CR70","unstructured":"Steel, R. G. D. & Torrie, J. H. Principles and Procedures of Statistics: a Biometrical Approach. (McGraw-Hill Kogakusha Ltd, 1980)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15971-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15971-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15971-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:58:50Z","timestamp":1670273930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15971-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["15971"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-15971-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"2 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1990"}}